Skip to main content
HR 760 103th Congress House Commerce Biotechnology Foreign Trade and International Finance Imports Patents

To amend title 35, United States Code, with respect to patents on certain processes.

Introduced: February 3, 1993 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 103rd Congress ended
It never became law before the 103rd Congress (1993–1994) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 6 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 16, 1994
See H.R.4307.
Jun 9, 1993
Subcommittee Hearings Held.
Feb 10, 1993
Referred to the Subcommittee on Intellectual Property and Judicial Administration.
Feb 3, 1993
Referred to the House Committee on Judiciary.
Feb 3, 1993
Sponsor introductory remarks on measure. (CR E256-257, E260)
Feb 3, 1993
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

TABLE OF CONTENTS:

Title I: Biotechnological Process Patents

Title II: Biotechnological Material Patents

Title I: Biotechnological Process Patents - Amends Federal patent law to cite conditions under which a claimed process of making or using a machine, manufacture, or composition of matter is not obvious (thereby enhancing the patentability prospects of certain biotechnology processes).

Establishes a presumption of validity with respect to a process claim even through a related product claim is invalidated (thus allowing a patentee to prove that the process claim is independently patentable from the product claim).

Title II: Biotechnological Material Patents - Makes any unauthorized person who imports or sells a product made by using a biotechnological material that is patented in the United States liable for patent infringement.

Includes within the terms of such patents the right to exclude others from using, selling, or importing such products throughout or into the United States.

Establishes exceptions to such requirements to the extent suitable to protect commercial investment made or business commenced before the effective date of such amendments.

What's happening now June 16, 1994

See H.R.4307.

 Related & companion bills 1
  • HR 4307 Procedurally related To amend title 35, United States Code, with respect to applications for process patents.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 2
All 2 Democratic 2
D
Nadler, Jerrold
New York · Nov 15, 1993
 D
Kaptur, Marcy
Ohio · Feb 17, 1993
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 760: To amend title 35, United States Code, with respect to patents on certain processes.. 103rd Congress. Open America. https://openamerica.io/bill/103-HR-760/
MLA
"H.R. 760: To amend title 35, United States Code, with respect to patents on certain processes.." 103rd Congress, 2026, Open America, https://openamerica.io/bill/103-HR-760/.
Bluebook (legal)
H.R. 760, 103rd Cong. (2026), https://openamerica.io/bill/103-HR-760/.
Markdown link
[H.R. 760: To amend title 35, United States Code, with respect to patents on certain processes.](https://openamerica.io/bill/103-HR-760/)
Report a problem